Skip to content
  1. Home
  2. Supplements
  3. L-Carnitine

L-Carnitine

An amino-acid derivative studied for body composition and exercise recovery.

Supplements

Recovery & healing Fitness & muscle

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

L-Carnitine

An amino-acid derivative studied for body composition and exercise recovery.

Evidence category: Systematic review. This describes the source category, not approval or certainty.

Regulatory statement in source: Not separately recorded; do not infer approval from the evidence category.

L-carnitine is a naturally occurring amino-acid derivative that shuttles fatty acids into cell mitochondria for energy production, and the body can synthesize it or obtain it from animal foods. It has been investigated in randomized trials for weight management, exercise recovery, and metabolic markers such as blood lipids and glycemic control. Meta-analyses report small but statistically significant reductions in body weight and markers of exercise-induced muscle damage, alongside more limited data on lipid and glucose outcomes.

Benefits reported in the imported source

  • Pooled trial data show a small but significant reduction in body weight and fat mass compared with placebo
  • May reduce muscle soreness and blood markers of exercise-induced muscle damage in the day after exercise

Risks and limits

  • Effect sizes for weight loss are modest and mainly seen in people with overweight or obesity
  • Gastrointestinal upset and a fishy body odor have been reported at higher intakes in some trials

Source bottom line: Randomized trial evidence supports small benefits for body composition and post-exercise muscle soreness, but effect sizes are modest and most robust in specific populations such as adults with obesity or untrained exercisers.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

Thirty-seven randomized controlled trials, 2292 adult participants, mostly with overweight or obesity

Reported regimen
Pooled dose-response analysis of oral L-carnitine trials ranging from 500 mg to 4 g per day for durations from 4 weeks up to a year
Duration
Four weeks up to one year
Reported outcome
Significant reductions in body weight, body mass index, and fat mass compared with placebo, with a non-linear dose-response curve suggesting a plateau near 2000 mg per day and no significant effect on waist circumference
Source
Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis - PubMed
Claim provenance

evidence.json#/catalog:supplement:l-carnitine/protocols/0

Seven randomized controlled trials in resistance-trained and untrained adults performing damaging exercise bouts

Reported regimen
Pooled analysis of oral L-carnitine supplementation trials, most using 1 to 3 g per day taken before or after exercise for one to three weeks
Duration
One to three weeks around the exercise bout
Reported outcome
Significant reductions in muscle soreness and in creatine kinase, myoglobin, and lactate dehydrogenase measured one day post-exercise compared with placebo, with effects most consistent in untrained participants
Source
The Effect of L-Carnitine Supplementation on Exercise-Induced Muscle Damage: A Systematic Review and Meta-Analysis - PubMed
Claim provenance

evidence.json#/catalog:supplement:l-carnitine/protocols/1

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

Historical research outcome: no-verified-description · 2026-10-06

No suitable community description was independently verified in these checks. The entry remains empty; this does not establish that no practice exists elsewhere.

Pharmacokinetic context

Historical half-life estimate: 3.9–6.5 hours. Harper et al. 1988, Eur J Clin Pharmacol, PMID 3234464 — oral, dose-dependent (2-6 g). The FDA's IV label (Carnitor) quotes 17.4 hours, but that figure is uncorrected for endogenous carnitine background and reflects the IV route Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

Snapshot provenance

Source ID: catalog:supplement:l-carnitine. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.

Related entries and components

None listed.